Viewing Study NCT01598220


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-03-02 @ 8:40 PM
Study NCT ID: NCT01598220
Status: COMPLETED
Last Update Posted: 2012-05-18
First Post: 2012-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Computer Assisted Cognitive Remediation Program in Schizophrenia
Sponsor: Gemma Garrido GarcĂ­a
Organization:

Study Overview

Official Title: Efficacy Study of a Computer Cognitive Remediation Program in Patients With Schizophrenia
Status: COMPLETED
Status Verified Date: 2012-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CACREPS
Brief Summary: The purpose of this study is to determine whether computer-assisted cognitive remediation therapy is effective in the treatment of cognitive deficits in schizophrenia.
Detailed Description: Schizophrenia can be considered a chronic illness that affects all aspects of daily life. Cognitive deficits seems to play a key role that interferes directly in the functional adaptation.

Cognitive remediation therapy (CRT) emerges as a psychological intervention that target cognitive impairment. But, the use of computerized or papel an pencil procedures for remediation cognitive deficits remains controversial. Nonetheless, computer tasks offer a number of advantages compared to those of paper and pencil. The most noteworthy advantages are to enhance patient's motivation just because the sensory variety that the exercises presented or the possibility to provide immediate feedback. Furthermore, the possibility to present custom-tailored and adapted tasks taking into accounts the patients deficits and their evolution in the process of the psychological therapy is another important feature of computer-assisted cognitive remediation therapy.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: